back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-05-18 Tx date 2017-05-08 |
$SL
Supreme Pharmaceuticals Inc. |
Factor, Ronald A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2017-05-18 Tx date 2017-05-08 |
$SL
Supreme Pharmaceuticals Inc. |
Factor, Ronald A.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2017-05-18 Tx date 2017-05-08 |
$SL
Supreme Pharmaceuticals Inc. |
Factor, Ronald A.
4 - Director of Issuer
Holder: RSP account (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,000 | ||
| Filed 2017-05-18 Tx date 2017-05-08 |
$SL
Supreme Pharmaceuticals Inc. |
Factor, Ronald A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-18 Tx date 2017-05-08 |
$SL
Supreme Pharmaceuticals Inc. |
Factor, Ronald A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-22 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-22 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+2,316,160 vol |
||
| Filed 2016-12-22 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+2,316,160 vol |
||
| Filed 2016-12-22 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2016-12-22 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
28,125 | ||
| Filed 2016-12-22 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-22 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+2,316,160 vol |
4,316,160 | |
| Filed 2016-12-21 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+2,316,160 vol |
||
| Filed 2016-12-21 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+2,316,160 vol |
||
| Filed 2016-12-21 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+2,316,160 vol |
||
| Filed 2016-12-21 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-21 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+2,316,160 vol |
||
| Filed 2016-12-21 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-21 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Holder: Chuck Rifici Holdings Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
2,028,125 | ||
| Filed 2016-12-21 Tx date 2016-12-16 |
$SL
Supreme Pharmaceuticals Inc. |
Rifici, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 |